LENSAR (LNSR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Jun, 2026Executive summary
Annual meeting scheduled for August 4, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by August 3, 2026, 11:59 PM ET.
Voting matters and shareholder proposals
Election of three Class III directors: Thomas B. Ellis, Richard L. Lindstrom, MD, and William J. Link, PhD.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026.
Advisory vote on executive compensation (say-on-pay) and on the frequency of future say-on-pay votes.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Board nominees for Class III director positions are presented for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from LENSAR
- Q2 2026 delivered 18% revenue growth, record profitability, and strong recurring revenue.LNSR
Q2 2026 - Directors re-elected, auditor ratified, and annual advisory votes on compensation approved.LNSR
AGM 2026 - Annual meeting to vote on directors, auditor, executive pay, and say-on-pay frequency, with strong governance.LNSR
Proxy filing - Robotic laser system accelerates growth, efficiency, and outcomes in cataract surgery.LNSR
Corporate presentation - Recurring revenue rose 9% to 94% of total as net income rebounded on one-time gains.LNSR
Q1 2026 - Recurring revenue rose 15% in 2025, with ALLY installations up 48% and net loss sharply reduced.LNSR
Q4 2025 - Q3 2024 revenue up 38% to $13.5M, with ALLY growth and positive Adjusted EBITDA despite ongoing risks.LNSR
Q3 2024 - ALLY's AI-powered laser system drives efficiency, superior outcomes, and rapid global expansion.LNSR
H.C. Wainwright 26th Annual Global Investment Conference 2024 - Record Q2 revenue and ALLY placements, global expansion, and break-even adjusted EBITDA.LNSR
Q2 2024